Skip to content

Ying Peng, MD, PHD

NPI 1528156429ActiveIndividual· Pediatrics, Neurodevelopmental Disabilities· Ladera Ranch, CA

Pediatrics, Neurodevelopmental Disabilities (MD, PHD) in Ladera Ranch, California, licensed in CA, with an NPI issued in October 2006. Their prescriptions cost Medicare Part D more than their services did: $1,597,561 for 301 claims, against $49,517 paid for services in 2024. Ucb, Inc. was the largest of 23 companies reporting payments in 2025, $3,532 in all, mostly food and beverage.

Overview

NPI1528156429
StatusActive
Entity typeIndividual
CredentialMD, PHD
Sole proprietorNo
NPI issuedOct 10, 2006
Last updated in NPPESNov 16, 2020
Certified by providerNov 16, 2020

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Neurodevelopmental Disabilities Primary2080P0008XA72981CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Neurology (CA)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients29
Services billed817 across 14 procedure codes
Paid by Medicare$49,517

Part D prescriptions in 2024

Prescriptions (claims)301 · 470 30-day fills
Patients27
Total drug cost$1,597,561
Generic share54% of claims

Medicare sources and data years

Education and affiliations

Graduation year1996
Medicare specialtyNeurology
Secondary specialtiesPediatric Medicine

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$3,532 · 110 payments from 23 companies
  • 2024$3,659 · 140 payments from 21 companies

Top paying companies in 2025

CompanyAmountPayments
Ucb, Inc.$982.4521
Argenx US, Inc.$326.9610
Grifols USA, LLC$232.286
Tris Pharma Inc$193.4015
Supernus Pharmaceuticals, Inc.$192.704

What the 2025 payments were for

  • Food and Beverage$3,520 · 109 payments
  • Education$11.71 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records